Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:approvedBy |
gptkb:COVID-19
|
| gptkbp:ATCCode |
J05AX27
|
| gptkbp:CASNumber |
gptkb:2094146-57-0
|
| gptkbp:component |
gptkb:Paxlovid
|
| gptkbp:developedBy |
gptkb:Pfizer
|
| gptkbp:drugClass |
antiviral
|
| gptkbp:hasInChIKey |
GGXKCSFZOLZRSR-GZNLZODZSA-N
|
| gptkbp:hasMolecularFormula |
C23H32F3N5O4
|
| gptkbp:hasSMILES |
CC1(C)[C@@H]2C[C@@H](N2C1)C(=O)N[C@@H](C#N)C[C@H]3CCNC3=O
|
| gptkbp:hasUNII |
QHU7246BXD
|
| https://www.w3.org/2000/01/rdf-schema#label |
2094146-57-0
|
| gptkbp:IUPACName |
(1R,2S,5S)-N-((1S)-1-cyano-2-((3S)-2-oxopyrrolidin-3-yl)ethyl)-3-((2S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:molecularWeight |
499.53 g/mol
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL4297599
155903259 DB16357 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:synonym |
gptkb:Nirmatrelvir
|
| gptkbp:target |
gptkb:SARS-CoV-2_main_protease
|
| gptkbp:bfsParent |
gptkb:MPO-12
|
| gptkbp:bfsLayer |
8
|